This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: The Administrators of the Tulane Educational Fund. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gretna, LA (US) (2015)
- New Orleans, LA (US) (2014 - 2016)
Company Filing History:
Years Active: 2014-2016
Title: Min Li: Innovator in Kidney Treatment
Introduction
Min Li is a notable inventor based in New Orleans, LA (US), recognized for his contributions to medical science, particularly in the treatment of kidney-related conditions. He holds a total of 3 patents, showcasing his innovative approach to healthcare.
Latest Patents
One of Min Li's latest patents focuses on the use of pituitary adenylate cyclase-activating polypeptide (PACAP) and its analogs for treating contrast-induced nephropathy. This invention features methods and compositions aimed at treating, managing, preventing, or reducing kidney injury caused by iodinated radiocontrast media. The methods involve administering effective amounts of PACAP-like compounds, including native human PACAP38, native human PACAP27, and vasoactive intestinal peptide (VIP), along with their agonists, analogs, fragments, and derivatives. Additionally, the patent provides pharmaceutical compositions that can be used in conjunction with other therapeutic agents to protect the kidneys during treatment with iodinated radiocontrast media. Another significant patent addresses the treatment of renal dysfunction and multiple myeloma using PACAP compounds. This invention outlines methods for managing these conditions through the administration of PACAP compounds, which include PACAP and VIP, along with their derivatives.
Career Highlights
Min Li has made significant strides in his career, particularly through his work with The Administrators of the Tulane Educational Fund and The Administrators of Tulane. His research and innovations have contributed to advancements in medical treatments, particularly in nephrology.
Collaborations
Min Li has collaborated with notable colleagues, including David H. Coy and Jerome L. Maderdrut. Their combined expertise has furthered the development of innovative treatments in the medical field.
Conclusion
Min Li's work exemplifies the impact of innovation in healthcare, particularly in the treatment of kidney-related conditions. His patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile